Lesley Dibley1,2, Ailsa Hart3, Julie Duncan4,5, Charles H Knowles6, Sally Kerry7, Doris Lanz7, Vichithranie W Madurasinghe7,8, Tiffany Wade9, Helen Terry10, Azmina Verjee11, Mandy Fader12, Christine Norton9. 1. Florence Nightingale Faculty of Nursing, Midwifery and Palliative, King's College London, James Clerk Maxwell Building, 57 Waterloo Road, London, SE1 8WA, UK. L.B.Dibley@Greenwich.ac.uk. 2. Centre for Chronic Illness and Ageing, Institute for Lifecourse Development, School of Health Sciences, Faculty of Education, Health and Human Sciences, University of Greenwich (Southwood Site), Rm G208, Grey Building, Avery Hill Road, Eltham, London, SE9 2 UG, UK. L.B.Dibley@Greenwich.ac.uk. 3. St Mark's Hospital (IBD Unit), Northwick Park Hospital, Watford Road, Harrow, Middlesex, HA1 3UJ, UK. 4. Department of Gastroenterology, St Thomas' Hospital, Westminster Bridge Road, London, SE1 7EH, UK. 5. Takeda UK, London, UK. 6. Blizard Institute, Barts and The London School of Medicine and Dentistry, The Blizard Building, 4 Newark Street, London, E1 2AT, UK. 7. Pragmatic Clinical Trials Unit (PCTU), Centre for Primary Care and Public Health, Queen Mary University, London (Whitechapel Campus), Yvonne Carter Building, 58 Turner Street, London, E1 2AB, UK. 8. University of Oxford, Oxford, UK. 9. Florence Nightingale Faculty of Nursing, Midwifery and Palliative, King's College London, James Clerk Maxwell Building, 57 Waterloo Road, London, SE1 8WA, UK. 10. Crohn's and Colitis UK, 1 Bishops Square, Hatfield Business Park, Hatfield, AL10 9NE, UK. 11. Patient and Public Involvement Team Lead, London, UK. 12. School of Health Sciences, University of Southampton, Southampton, UK.
Abstract
OBJECTIVES: To test two methods for reporting of fecal incontinence (FI) in people with inflammatory bowel disease. METHODS: Consecutive patients from IBD clinics in six UK hospitals completed a short three-item case-finding survey about FI; they either completed the survey themselves or were asked the same questions face to face by a clinician. RESULTS: Of 1336 eligible patients with complete data (48% male; mean 43 years; 55% Crohn's disease, 41% ulcerative colitis), 772 were asked about FI face to face, and 564 self-completed the survey: FI was reported in 63% and 56%, respectively (p = 0.012). In regression analyses, those aged 51-60, having Crohn's disease and higher disease activity, were more likely to report FI. Of all respondents, 38.7% were interested in receiving help for their incontinence. CONCLUSIONS: Fecal incontinence affects the majority of people with IBD. Although more patients reported fecal incontinence when asked face to face than self-reported, routine screening by either method in clinical practice is recommended. Over one-third of patients with IBD want help for bowel control problems.
OBJECTIVES: To test two methods for reporting of fecal incontinence (FI) in people with inflammatory bowel disease. METHODS: Consecutive patients from IBD clinics in six UK hospitals completed a short three-item case-finding survey about FI; they either completed the survey themselves or were asked the same questions face to face by a clinician. RESULTS: Of 1336 eligible patients with complete data (48% male; mean 43 years; 55% Crohn's disease, 41% ulcerative colitis), 772 were asked about FI face to face, and 564 self-completed the survey: FI was reported in 63% and 56%, respectively (p = 0.012). In regression analyses, those aged 51-60, having Crohn's disease and higher disease activity, were more likely to report FI. Of all respondents, 38.7% were interested in receiving help for their incontinence. CONCLUSIONS: Fecal incontinence affects the majority of people with IBD. Although more patients reported fecal incontinence when asked face to face than self-reported, routine screening by either method in clinical practice is recommended. Over one-third of patients with IBD want help for bowel control problems.